德英生物科技
News

Event News

2025.07.23

Event News

Geherbs Expands International Market, Achieves Record Revenue

▶ SR-T100 Plant-based New Drug:

Targeting malignant ascites in cancer, making innovative breakthroughs towards human clinical trials!

▶ Accelerating International Expansion:

In partnership with Ba Ma, LiBaoGan has entered 16 countries globally, with exclusive pharmacies across Taiwan!

▶ Record Revenue:

Achieving double-digit monthly growth in the first half of the year, ranking among the top three SMEs!

▶ Social Contribution:

Chairman Guo Guohua upholds the philosophy of "helping and saving lives,"
and established the "Cancer Prevention Charity Foundation" in his father's name to support patients in receiving proper treatment.

Geherbs focuses on “Research & Development” to step onto the global stage!

※ Source | Economic Daily News, Reporter Wu Guodong, 2025/7/22